The management and breeding of a large colony constitutes a major component of the genetic analysis of murine models of human diseases, requiring substantial effort in time and money. This mouse core will be the major component of the Wakeland mouse colony (WMC), which breeds and maintains an SPF colony that currently consists of >2000 mice. We have four specific aims:
Specific aim 1. To maintain our collection of congenic strains and provide production mice as needed by the program project. A total of 23 strains are currently bred and maintained within the WMC. The core will be responsible for maintaining breeding records and overseeing the production of mice for experiments as needed by program project personnel.
Specific aim 2. Production and maintenance of crosses. Large scale testcrosses and gene introgressions that are required by program project personnel will be supported by this core.
Specific aim 3. Clinical and histological evaluations by SLE phenotypes. Several of the strains within this collection are susceptible to spontaneous systemic autoimmunity. These strains are inspected daily and monitored for proteinuria on a weekly basis beginning at 5 months of age. In addition, all tissue processing and histopathology will be centralized in Core B and performed under the supervision of Dr. Zhou.
Specific aim 4. Derivation and importation of SPF strains. The WMC is housed in SPF conditions in a barrier facility. Importation of new strains is carefully monitored and in many instances, strains must be derived SPF prior to their admission into the facility. The WMC will develop Caesarian -derivation procedures for conversion to SPF status and supply this as a service to program project personnel. We anticipate that usage of this core will be: 70% Project 1, 25% Project 2, and 5% Projects 3 & 4.

Project Start
2000-09-15
Project End
2001-08-31
Budget Start
Budget End
Support Year
6
Fiscal Year
2000
Total Cost
Indirect Cost
City
Dallas
State
TX
Country
United States
Zip Code
75390
Luo, Wei; Mayeux, Jessica; Gutierrez, Toni et al. (2014) A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels. J Immunol 193:909-920
Cuda, Carla M; Misharin, Alexander V; Gierut, Angelica K et al. (2014) Caspase-8 acts as a molecular rheostat to limit RIPK1- and MyD88-mediated dendritic cell activation. J Immunol 192:5548-60
Dozmorov, Igor; Dominguez, Nicolas; Sestak, Andrea L et al. (2013) Evidence of dynamically dysregulated gene expression pathways in hyperresponsive B cells from African American lupus patients. PLoS One 8:e71397
Gutierrez, Toni; Mayeux, Jessica M; Ortega, Sterling B et al. (2013) IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice. Eur J Immunol 43:382-93
Cuda, Carla M; Agrawal, Hemant; Misharin, Alexander V et al. (2012) Requirement of myeloid cell-specific Fas expression for prevention of systemic autoimmunity in mice. Arthritis Rheum 64:808-20
Gutierrez, Toni; Halcomb, Kristina E; Coughran, Alanna J et al. (2010) Separate checkpoints regulate splenic plasma cell accumulation and IgG autoantibody production in Lyn-deficient mice. Eur J Immunol 40:1897-905
Wang, Andrew; Guilpain, Philippe; Chong, Benjamin F et al. (2010) Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus. Arthritis Rheum 62:3436-46
Jacob, Chaim O; Zhu, Jiankun; Armstrong, Don L et al. (2009) Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A 106:6256-61
Wang, Andrew; Fairhurst, Anna-Marie; Tus, Katalin et al. (2009) CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus. J Immunol 182:4448-58
Fairhurst, Anna-Marie; Mathian, Alexis; Connolly, John E et al. (2008) Systemic IFN-alpha drives kidney nephritis in B6.Sle123 mice. Eur J Immunol 38:1948-60

Showing the most recent 10 out of 30 publications